348 related articles for article (PubMed ID: 35221331)
61. Methanosarcina acetivorans contains a functional ISC system for iron-sulfur cluster biogenesis.
Deere TM; Prakash D; Lessner FH; Duin EC; Lessner DJ
BMC Microbiol; 2020 Oct; 20(1):323. PubMed ID: 33096982
[TBL] [Abstract][Full Text] [Related]
62. Frataxin and mitochondrial FeS cluster biogenesis.
Stemmler TL; Lesuisse E; Pain D; Dancis A
J Biol Chem; 2010 Aug; 285(35):26737-26743. PubMed ID: 20522547
[TBL] [Abstract][Full Text] [Related]
63. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
64. CpSufE activates the cysteine desulfurase CpNifS for chloroplastic Fe-S cluster formation.
Ye H; Abdel-Ghany SE; Anderson TD; Pilon-Smits EA; Pilon M
J Biol Chem; 2006 Mar; 281(13):8958-69. PubMed ID: 16455656
[TBL] [Abstract][Full Text] [Related]
65. Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex.
Tsai CL; Barondeau DP
Biochemistry; 2010 Nov; 49(43):9132-9. PubMed ID: 20873749
[TBL] [Abstract][Full Text] [Related]
66. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
67. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
Zhou Y; He A; Zhang L; Yi G
Neoplasma; 2020 Mar; 67(2):296-303. PubMed ID: 31884801
[TBL] [Abstract][Full Text] [Related]
68. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.
Liu W; Zhang Z; Zhang Y; Chen X; Guo S; Lei Y; Xu Y; Ji C; Bi Z; Wang K
Cancer Biol Ther; 2015; 16(4):511-7. PubMed ID: 25778491
[TBL] [Abstract][Full Text] [Related]
69. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
[TBL] [Abstract][Full Text] [Related]
70. Mechanism of frataxin "bypass" in human iron-sulfur cluster biosynthesis with implications for Friedreich's ataxia.
Das D; Patra S; Bridwell-Rabb J; Barondeau DP
J Biol Chem; 2019 Jun; 294(23):9276-9284. PubMed ID: 30975898
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (
Combès E; Andrade AF; Tosi D; Michaud HA; Coquel F; Garambois V; Desigaud D; Jarlier M; Coquelle A; Pasero P; Bonnefoy N; Moreaux J; Martineau P; Del Rio M; Beijersbergen RL; Vezzio-Vie N; Gongora C
Cancer Res; 2019 Jun; 79(11):2933-2946. PubMed ID: 30987998
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
73. Essential role of Isd11 in mitochondrial iron-sulfur cluster synthesis on Isu scaffold proteins.
Wiedemann N; Urzica E; Guiard B; Müller H; Lohaus C; Meyer HE; Ryan MT; Meisinger C; Mühlenhoff U; Lill R; Pfanner N
EMBO J; 2006 Jan; 25(1):184-95. PubMed ID: 16341089
[TBL] [Abstract][Full Text] [Related]
74. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
75. Effector role reversal during evolution: the case of frataxin in Fe-S cluster biosynthesis.
Bridwell-Rabb J; Iannuzzi C; Pastore A; Barondeau DP
Biochemistry; 2012 Mar; 51(12):2506-14. PubMed ID: 22352884
[TBL] [Abstract][Full Text] [Related]
76. Friedreich's ataxia variants I154F and W155R diminish frataxin-based activation of the iron-sulfur cluster assembly complex.
Tsai CL; Bridwell-Rabb J; Barondeau DP
Biochemistry; 2011 Jul; 50(29):6478-87. PubMed ID: 21671584
[TBL] [Abstract][Full Text] [Related]
77. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
78. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction.
Fujihara KM; Zhang BZ; Jackson TD; Ogunkola MO; Nijagal B; Milne JV; Sallman DA; Ang CS; Nikolic I; Kearney CJ; Hogg SJ; Cabalag CS; Sutton VR; Watt S; Fujihara AT; Trapani JA; Simpson KJ; Stojanovski D; Leimkühler S; Haupt S; Phillips WA; Clemons NJ
Sci Adv; 2022 Sep; 8(37):eabm9427. PubMed ID: 36103522
[TBL] [Abstract][Full Text] [Related]
79. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
Wang Y; Lu JH; Wang F; Wang YN; He MM; Wu QN; Lu YX; Yu HE; Chen ZH; Zhao Q; Liu J; Chen YX; Wang DS; Sheng H; Liu ZX; Zeng ZL; Xu RH; Ju HQ
Cancer Lett; 2020 Mar; 473():74-89. PubMed ID: 31904482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
